Twelve men, four days, six months of sequencing
In a trial published in Nature Microbiology in 2018, 12 healthy men took a 4-day course of three broad-spectrum antibiotics while researchers tracked their gut bacteria by sequencing stool samples over six months.
The design was simple: get a baseline reading of each man's gut microbiome, disrupt it with a short, intensive antibiotic course, then watch what happened as the body rebuilt its bacterial population without any other intervention.
This kind of study is rare because it follows the same small group of people for a long stretch of time, rather than comparing different people at a single point. That makes the six-month data unusually detailed, even though the sample size of 12 is small.
How a 4-day course reshapes the gut in days
The trial found that some bacterial groups were hit hard almost immediately. Bifidobacterium species and several butyrate-producing bacteria dropped sharply in the first few days after the antibiotics began.
Butyrate-producing bacteria matter because butyrate is a molecule these microbes make when they ferment fibre in the gut. Losing the bacteria that produce it does not itself cause harm, but it does remove a byproduct that researchers have linked to gut lining function in other studies.
The speed of the decline is the notable part here: broad-spectrum antibiotics do not discriminate between the bacteria causing an infection and the unrelated bacteria living in the gut, so a short course can suppress many species within days, not weeks.
Six weeks to look normal, six months to find the gaps
According to the 2018 Nature Microbiology paper, the men's gut microbiomes returned to something close to their starting composition within about six weeks of finishing the antibiotics.
That recovery looked reassuring on the surface. But when the researchers kept sequencing for six months total, they found 9 common species that had still not returned in most of the 12 participants.
This is the distinction between overall similarity and species-level detail. A microbiome can look broadly 'back to normal' in terms of overall diversity while specific species remain absent, because other bacteria expand to fill the space they left.
What this does and doesn't tell us about fibre
The 2018 trial did not test fibre intake, supplementation, or diet changes as a way of encouraging bacterial recovery. It measured only what happened after antibiotics, with no dietary intervention arm.
Separately, other research has looked at whether dietary fibre is associated with higher levels of butyrate-producing bacteria in the gut, since these bacteria rely on fibre as a fermentation substrate. That association does not establish that eating more fibre after a course of antibiotics restores the missing species identified in this trial.
It is also worth being clear about scale: 12 participants, all healthy men, in one country, using one specific antibiotic combination. Different antibiotics, doses, or health conditions could produce different patterns of loss and recovery, and this study alone cannot predict what happens in a larger or more varied population.
What to watch for in future research
Because this was an observational tracking study rather than a test of any recovery strategy, it raises a clear question without answering it: does adding more fermentable fibre to the diet change how quickly, or how completely, bacteria repopulate after antibiotics.
Anyone curious about their own gut bacteria after a course of antibiotics is dealing with a system that, based on this evidence, may still be missing some long-term residents six months later, well after they feel back to normal.